(*RealFX Q-Plus™ was rebranded as Q-Force™ in 2010)
Quercetin has been the subject of over 7,000 research studies and the Company's QU995™ has been used in U.S. Department of Defense funded clinical trials in animals and humans since 2006.
"Quercetin exerts strong anti-oxidative, anti-inflammatory, anti-pathogenic, and immune regulatory effects in vitro and in animal-based studies. Epidemiological data indicates reduced rates of cardiovascular disease and various types of cancer in groups self-selecting diets high in Quercetin. Several recent supplementation studies in athletes have focused on Quercetin's potential influences as a countermeasure to post-exercise inflammation, oxidative stress, and immune dysfunction, in improving endurance performance, and in reducing illness rates following periods of physiological stress."
--David C. Nieman, DrPH, FACSM
Director, Human Performance Lab, North Carolina Research Campus
Professor, Appalachian State University
About Quercegen Pharmaceuticals
Quercegen Pharmaceuticals and its affiliates research, develop, manufacture, and market proprietary plant-derived pharmaceutical ingredients and nutraceutical products in the U.S. and abroad. One of the Company's affiliates, Quercegen Agronegocios, is the world's largest producer of Quercetin and operates a 3,600 hectare farm in northern Brazil. It processes plant materials into crude Rutin and Quercetin for purification at its plant in Sao Luiz and the resulting purified products are shipped around the world for inclusion in pharmaceuticals, dietary supplements and foodstuffs.
Quercegen together with Merck S.A. developed QU995™, the World's Purest Quercetin™, through a patented extraction and purification process. The Company has improved the bioavailability of the flavonoid Quercet
|SOURCE Quercegen Pharmaceuticals LLC|
Copyright©2010 PR Newswire.
All rights reserved